20277 results for «»

Filter By

20277 results

Treatment dilemma: how should I treat an isolated CX or LAD stenosis

19 May 2022 – From EuroPCR 2022

Treatment dilemma: how

PCR Tokyo Valves 2022 - A dedicated series of 6 live webinars to enjoy

28 Jun 2022

 

 

Watch replay for free now!

This year’s PCR Tokyo Valves took the form of a dedicated series of 6 live webinars. They took place from September to December 2022, last one hour each, and are all in English. They address a broad range of issues in structural...

PCR Tokyo Valves 2022 – Join your peers for a series of 6 CME-accredited live webinars!

EuroIntervention's new Impact Factor!

28 Jun 2022

The EuroIntervention Journal is pleased to announce its 2021 Impact Factor: 7.728 (2021 Journal Citation Reports® Science Edition (Clarivate Analytics, 2022)

With this result, we confirm last year's progression and we are proud to be listed 2nd amongst interventional cardiology journals. 

EuroIntervention's new Impact Factor!

What's new in primary PCI - a closer look at challenging STEMI settings

19 May 2022 – From EuroPCR 2022

What's new in primary

Treatment dilemma: primary PCI in different clinical scenarios

19 May 2022 – From EuroPCR 2022

Treatment dilemma: primary

What's new in TAVI - a closer look on procedural planning and device selection

19 May 2022 – From EuroPCR 2022

What's new in TAVI -

Daily news

19 May 2022 – From EuroPCR 2022

Daily news

Late-breaking science overview - What did we learn @EuroPCR 2022?

20 May 2022 – From EuroPCR 2022

Watch this video to gain insight into late-breaking studies and trials presented during EuroPCR 2022:

  • Intravascular imaging vs. angiography-guided PCI in high bleeding risk patients
  • Trancatheter Aortic Valve Repair for aortic insufficiency using the Cusper device
  • Angiography-derived coronary microcirculatory assessment in INOCA patients
  • Blood pressure and MACE reductions after renal...
Late-breaking science overview - What did we learn @EuroPCR 2022?

EuroPCR 2022 in words and images - What did we learn this year?

20 May 2022 – From EuroPCR 2022

Watch this video to get a brief look at the highlights of EuroPCR 2022 and learn about the:

  • 30 years radial interview (Jean Fajadet)
  • PCR's Got Talent winner interview
  • Top 3 memories on coronary: ROBOTIC PCI, simulation-based learning on stent dislodgment and U-REDUCE STENT registry
  • Top 3 publications EuroIntervention and...
EuroPCR 2022 in words and images - What did we learn this year?

The importance of hemodynamic performance in transcatheter aortic valves

04 Jul 2022

Watch the 1st of #PCRtokyo 2022’s six live webinars about ‘The importance of hemodynamic performance in transcatheter aortic valves’.

The importance of hemodynamic performance in transcatheter aortic valves

Emerging indications for TAVI

17 May 2022 – From EuroPCR 2022

Emerging indications

Ultrathin, biodegradable-polymer sirolimus-eluting stent vs thin, durable-polymer everolimus-eluting stent

06 Jul 2022

The CASTLE trial is a randomised multicentre prospective non-inferiority trial comparing ultra-thin strut bioresorbable polymer and thin strut durable polymer drug eluting stents implanted with intracoronary imaging guidance.

Nicola Ryan

Reviewer

Nicola Ryan
Ultrathin, biodegradable-polymer sirolimus-eluting stent vs thin, durable-polymer everolimus-eluting stent

3-year outcomes after a 2-stent with provision stenting for complex bifurcation lesions defined by DEFINITION criteria

06 Jul 2022

DEFINITION II was a randomised control trial comparing PCI in complex bifurcation lesions using a two-stent technique versus a provisional stenting strategy. At one year follow-up, a two-stent technique was superior to a provisional approach in true complex bifurcations. Here, the authors present the 3-year clinical outcomes...

Nicola Ryan

Reviewer

Nicola Ryan
3-year outcomes after a 2-stent with provision stenting for complex bifurcation lesions defined by DEFINITION criteria

Streamlining transfemoral TAVI in patients with peripheral atherosclerosis

17 May 2022 – From EuroPCR 2022

Streamlining transfemoral

PCRonline @ ESC Congress 2022: the interventional cardiology perspective!

18 Jul 2022

Stay up to date with what was new and hot in interventional cardiology at the #ESCCongress 2022!

PCRonline @ ESC Congress 2022

TAVI durability: important considerations for patient lifetime management

18 May 2022 – From EuroPCR 2022

TAVI durability: important

Managing acute coronary perforation: a simulation-based team approach

18 May 2022 – From EuroPCR 2022

Managing acute coronary

Radial versus femoral access in ACS patients undergoing complex PCI is associated with consistent bleeding benefit and no excess of risk

18 Jul 2022

In this paper, the authors investigated the comparative efficacy and safety of TRA versus TFA in ACS patients undergoing complex PCI in the Minimizing Adverse Haemorrhagic Events by TRansradial Access Site and Systemic Implementation of angioX (MATRIX)-Access trial1.

Reviewer

Aaysha Cader

Reviewer

Ali Nazmi Calik
Radial versus femoral access in ACS patients undergoing complex PCI is associated with consistent bleeding benefit and no excess of risk

IVUS and OCT: when, how, why?

18 May 2022 – From EuroPCR 2022

IVUS and OCT: when, how,

Evaluation of the incidence of radial artery occlusion using different introducer sheaths and hemostasis techniques

19 Jul 2022

This retrospective observational study was undertaken in patients referred for transradial coronary angiography (CA) or PCI to assess the impact of sheath sizes and haemostasis techniques on RAO incidence.

Reviewer

Aaysha Cader
Radial versus femoral access in ACS patients undergoing complex PCI is associated with consistent bleeding benefit and no excess of risk
Didn’t find what you were looking for?